Blood-borne Infections (BBIs) – Sansure Biotech https://www.sansureglobal.com Innovating Diagnostics for All Wed, 15 Nov 2023 10:27:25 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 S3046E HIV-1 – Human Immunodeficiency Virus Type 1 RNA Quantitative Fluorescence Diagnostic Kit https://www.sansureglobal.com/product/s3046e-hiv-1/?utm_source=rss&utm_medium=rss&utm_campaign=s3046e-hiv-1 https://www.sansureglobal.com/product/s3046e-hiv-1/#respond Fri, 19 Aug 2022 12:08:22 +0000 https://www.sansureglobal.com/?post_type=product&p=4331 Brief The human immunodeficiency virus (HIV) is the causative agent for the worldwide AIDS epidemic, and it has taken nearly 33 million lives worldwide.​ Sansure's HIV-1 RNA Quantitative Fluorescence Diagnostic Kit is intended for quantitative detection of the HIV-1 Virus RNA in human EDTA plasma specimens. Sansure's HIV-1 RNA kit received CE certificate, supporting the company to provide more quality products and services for international customers, and to help prevent and control AIDS worldwide.

Performance

Patented Modified-Capture Probe Assay Using exclusive modified super-paramagnetic nano-beads to absorb DNA/RNA in the sample； Heating free: Innovative lysis solution, no heating, less aerosol contamination; Single wash step: Unique combination of inorganic and organic solutions for reduced handling steps and reduced HBV DNA loss. Dual Target LTR and GAG gene regions are selected as targets for HIV detection to avoid missed detection, which can improve detection efficiency. High Sensitivity 25 IU/mL, meeting HIV-1 infection clinic guidelines.  Internal Control The HIV-1 RNA Kits uses Internal Control is the full name to whole-process the HIV-1 extraction and amplification process to avoid false negative results.

Parameters

Product features Parameter
Specimen Type Plasma
Extraction Platform Advanced magnetic beads technology
Genotype HIV-1 Group M,N,O
Internal Control Pseudoviruses
PCR Instrument SLAN-96P, ABI7500, Roche cobas 480
Sensitivity 25 IU/mL
Linear range 50—1.0E+08 IU/mL
Spec. 48T
Qualification CE
]]> ]]> https://www.sansureglobal.com/product/s3046e-hiv-1/feed/ 0 C004E BCI – Nucleic Acid Test Kit for HBV, HCV, HIV (Type1+2) https://www.sansureglobal.com/product/c004e-bci/?utm_source=rss&utm_medium=rss&utm_campaign=c004e-bci https://www.sansureglobal.com/product/c004e-bci/#respond Wed, 25 May 2022 09:54:09 +0000 https://www.sansureglobal.com/?post_type=product&p=4057 Brief Nucleic Acid Test Kit for HBV,HCV,HIV(Type1+2), is based on real-time fluorescence PCR technology and used for nucleic acid qualitative detection of HBV, HCV, HIV1+2 in plasma.   This kit is intended for use as a blood donor screening test to detect HBV DNA, HCV RNA, HIV-1 RNA and HIV-2 RNA in pooled or individual sample from healthy blood donors, blood donors of various components (red blood cells, platelets and plasma) and other types of blood donors. All plasma to be tested can be screened as individual samples or tested in pools after mixing with each equal aliquots according to routine serological screening results HBV, HCV and HIV samples. For the pooled sample showed positive test results, carry out individual testing, the individual test result should be used as the final test result of this sample. The test results of this diagnostic kit can distinguish reactivity of between HBV, HCV and HIV.

Advantages

High sensitivity
  • HBV 2.41 IU/mL
  • HCV 12.38 IU/mL
  • HIV-1 31.68 IU/mL
  • HIV-2 48.34 IU/mL
High efficiency
  • 576 tests/ 5h（pooling）
  • 96 tests / 4.5h（single)
Complete subtypes coverage
  • HBV genotypes A-H
  • HCV genotypes 1-6
  • HIV-1 group M/N/O
  • HIV-2
Single pipe joint inspection
  • Four tests for a tube of samples
  • Direct discriminating positive
Automated detection
  • Extraction and amplification process
  • No need to be on duty
Cost and space savings
  • One extractor + one amplifier
  • Less consumable material consumption

Features

Sample preparation and extraction in one module Fully automatic sample preparation and nucleic acid extraction in one module to build up a integrated reaction system Flexible testing mode 6 pooling sample testing or individual donor testing (IDT) supported Advanced magnetic beads technology Nanometer-level beads enable beads-in-PCR amplification ensuring maximum nucleic acid template Patented magnetic beads lateral suction technology Thorough waste liquid removal allows minimal magnetic beads loss Sophisticated sample information processing Automatic recognition of the sample barcode & sample tracking and archiving table generation available High throughput 558/96 samples result output in one time Minimal system maintenance time Less than 20 minutes startup with fewer maintenance tasks Excellent accuracy A total number of 105,124 blood bags which confirmed as negative by serological testing were tested against some referential screening kits. 15 false-negative results in reference tests were found.

Parameters

Qualification CE
]]> ]]> https://www.sansureglobal.com/product/c004e-bci/feed/ 0 C003E BCI – Nucleic Acid Test Kit for HBV, HCV, HIV (Type1+2) https://www.sansureglobal.com/product/c003e-bci/?utm_source=rss&utm_medium=rss&utm_campaign=c003e-bci https://www.sansureglobal.com/product/c003e-bci/#respond Thu, 22 Jul 2021 08:01:55 +0000 http://v2.sansureglobal.com/?post_type=product&p=3164 Brief Nucleic Acid Test Kit for HBV, HCV, HIV (Type1+2), is based on real-time fluorescence PCR technology and used for nucleic acid qualitative detection of HBV, HCV, HIV1+2 in plasma.   This kit is intended for use as a blood donor screening test to detect HBV DNA, HCV RNA, HIV-1 RNA and HIV-2 RNA in pooled or individual sample from healthy blood donors, blood donors of various components (red blood cells, platelets and plasma) and other types of blood donors. All plasma to be tested can be screened as individual samples or tested in pools after mixing with each equal aliquots according to routine serological screening results HBV, HCV and HIV samples. For the pooled sample showed positive test results, carry out individual testing, the individual test result should be used as the final test result of this sample. The test results of this diagnostic kit can distinguish reactivity of between HBV, HCV and HIV.

Advantages

High sensitivity
  • HBV 3IU/mL
  • HCV 10IU/mL
  • HIV 45IU/mL
High efficiency
  • 576 tests/ 5h（pooling）
  • 45 tests / 4.5h（single
Complete subtypes coverage
  • HBV A-H
  • HCV 1-6
  • HIV-1（M/N/O）and HIV-2
Single pipe joint inspection
  • Four tests for a tube of samples
  • Direct discriminating positive
Automated detection
  • Extraction and amplification process
  • No need to be on duty
Cost and space savings
  • One extractor + one amplifier
  • Less consumable material consumption

Features

Sample preparation and extraction in one module Fully automatic sample preparation and nucleic acid extraction in one module to build up a integrated reaction system   Flexible testing mode 6 pooling sample testing or individual donor testing (IDT) supported   Advanced magnetic beads technology Nanometer-level beads enable beads-in-PCR amplification ensuring maximum nucleic acid template   Patented magnetic beads lateral suction technology Thorough waste liquid removal allows minimal magnetic beads loss   Sophisticated sample information processing Automatic recognition of the sample barcode & sample tracking and archiving table generation available   High throughput 558/45 samples result output in one time   Minimal system maintenance time Less than 20 minutes startup with fewer maintenance tasks   Excellent accuracy A total number of 105,124 blood bags which confirmed as negative by serological testing were tested against some referential screening kits. 15 false-negative results in reference tests were found.

Parameters

Qualification CE
]]> ]]> https://www.sansureglobal.com/product/c003e-bci/feed/ 0 S3034E HCV Genotype – Hepatitis C Virus Genotype Diagnostic Kit https://www.sansureglobal.com/product/s3034e-hcv-genotype/?utm_source=rss&utm_medium=rss&utm_campaign=s3034e-hcv-genotype https://www.sansureglobal.com/product/s3034e-hcv-genotype/#respond Thu, 22 Jul 2021 08:01:02 +0000 http://v2.sansureglobal.com/?post_type=product&p=3163 Brief By applying real-time PCR technology, the Hepatitis C Virus Genotype Diagnostic Kit (PCR-Fluorescence Probing) is designed for qualitative identification of HCV genotypes (including genotypes 1b, 1, 2, 3, 4, 5 and 6) from HCV RNA positive samples. The test results can be used as an aid in the identification of HCV genotypes and determination of an appropriate therapeutic treatment indicated for the above listed gentoypes. The results can be used only for clinical reference, and cannot be used as the only evidence for adjusting therapeutic drugs. Clinical symptoms and other laboratory test results should also be considered to comprehensively determine the patients treatment.

Parameters

Product features Parameter
Specimen Type serum
Extraction Platform Magnetic beads technologies
Genotype 1b, 1(1b, 1a), 2 (2a), 3 (3a, 3b), 4 (4a), 5 (5a), 6 (6a)
Internal Control Plasmid
PCR Instrument Mx3000P,Slan 96P
Sensitivity 1000 IU/mL
Spec. 12T
Qualification CE
]]> ]]> https://www.sansureglobal.com/product/s3034e-hcv-genotype/feed/ 0 S3119E HCV Ultra – Hepatitis C Virus RNA Quantitative Fluorescence Diagnostic Kit https://www.sansureglobal.com/product/s3119e-hcv-ultra/?utm_source=rss&utm_medium=rss&utm_campaign=s3119e-hcv-ultra https://www.sansureglobal.com/product/s3119e-hcv-ultra/#respond Thu, 22 Jul 2021 08:00:18 +0000 http://v2.sansureglobal.com/?post_type=product&p=3162 Brief Hepatitis C Virus RNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the quantification of HCV RNA in human serum or plasma. It is intended for use as an aid in the diagnosis of an HCV infection and observing drug efficacy. Hepatitis C is mainly caused by HCV infection and transmitted through blood. Chronic infection of HCV can lead to chronic inflammation of liver and fibrosis, and some patients may develop into liver cirrhosis, even Hepatocellular Carcinoma (HCC). It has huge harms on patients’ health and life quality, and has become a severe social and public health issue.

Parameters

Product features Parameter
Specimen Type Plasma
Extraction Platform Advanced magnetic beads technology
Genotype HCV 1-6 genotype
Internal Control Lentivirus particles
PCR Instrument SLAN-96P, ABI7500, Roche cobas 480
Sensitivity 12 IU/mL
Linear range 25—1.0E+08 IU/mL
Spec. 24T
Qualification CE
]]> ]]> https://www.sansureglobal.com/product/s3119e-hcv-ultra/feed/ 0 S3013E HBV fast – Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit https://www.sansureglobal.com/product/s3013e-hbv-fast/?utm_source=rss&utm_medium=rss&utm_campaign=s3013e-hbv-fast https://www.sansureglobal.com/product/s3013e-hbv-fast/#respond Thu, 22 Jul 2021 07:59:42 +0000 http://v2.sansureglobal.com/?post_type=product&p=3161 Brief Hepatitis B Viral (HBV) DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro nucleic acid amplification test for the quantification of HBV DNA in human serum or plasma. It can be used to evaluate antiviral treatment and monitor the therapeutic effect by monitoring HBV DNA baseline levels and changes in patient blood. Test results should not be taken as the only indicator for evaluation of diseases, but to be combined with patients clinical symptoms and other laboratory tests to analyze the diseases.

Parameters

Product features Parameter
Specimen Type Serum or plasma
Extraction Platform One-tube fast test release
Genotype HBV genotype A-H
Internal Control Plasmid
Compatible Instrument ABI7300 , Stratagene Mx3000P , Roche Light Cycler 480 , ABI7500, SLAN-96P and QuantStudio 5
Sensitivity 30 IU/mL
Linear range 100—5.0E+09 IU/mL
Spec. 24T, 48T
]]> ]]> https://www.sansureglobal.com/product/s3013e-hbv-fast/feed/ 0 S3118E HBV Ultra – Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit https://www.sansureglobal.com/product/s3118e-hbv-ultra/?utm_source=rss&utm_medium=rss&utm_campaign=s3118e-hbv-ultra https://www.sansureglobal.com/product/s3118e-hbv-ultra/#respond Thu, 22 Jul 2021 07:59:01 +0000 http://v2.sansureglobal.com/?post_type=product&p=3160 Brief Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing)  (HBV Ultra) is an in vitro nucleic acid amplification test for the quantification of Human HBV DNA in human serum. It is intended for use as an aid in diagnosing an HBV infection and observing drug efficacy.

Performance

Advanced magnetic beads technology HBV DNA detection and viral load measurement are essential for treatment decisions and patient monitoring. Sansure's HBV Ultra uses the advanced magnetic beads technology to extract HBV DNA from clinical Plasma.  Our technology achieved high sensitivity and wide linear range detection to meet of clinical diagnosis and follow-up needs.   Highly conservative primer probe design Sansure primers and probes target select the highly conservative S gene of HBV, which can cover A-H genotypes and avoid missed detection.   High-efficient quality control system HBV Ultra uses UNG enzyme + dUTP system to remove carry-over contamination to avoid a false positive result.   HBV Ultra uses Internal Control HBV Ultra uses Internal Control is the full name to whole-process the HBV extraction and amplification process to avoid false negative results.

Parameters

Product features Parameter
Specimen Type Plasma
Extraction Platform Advanced magnetic beads technology
Genotype HBV genotype A-H
Internal Control Pseudoviruses
PCR Instrument SLAN-96P, ABI7500, Roche cobas 480
Sensitivity 5 IU/mL
Linear range 20—2.0E+09 IU/mL
Spec. 48T
Qualification CE
]]> ]]> https://www.sansureglobal.com/product/s3118e-hbv-ultra/feed/ 0